Screener
Denali Therapeutics Inc. DNLI PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Denali Therapeutics Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:08 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001714899-26-000097
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Prepaid expenses and other current assets | 35,390 | 32,779 |
| Total current assets | 753,927 | 900,658 |
| Long-term marketable securities | 229,534 | 98,322 |
| Property and equipment, net | 49,926 | 52,402 |
| Finance lease right-of-use asset | 46,700 | 48,531 |
| Operating lease right-of-use asset | 16,793 | 19,002 |
| Intangible asset, net | 35,250 | — |
| Other non-current assets | 25,825 | 25,939 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Denali Therapeutics Inc.'s PP&E (net)?
- Denali Therapeutics Inc. (DNLI) reported PP&E (net) of $49.93M in Q2 2026.
- How has Denali Therapeutics Inc.'s PP&E (net) changed year-over-year?
- Denali Therapeutics Inc.'s PP&E (net) decreased by 15.0% year-over-year, from $58.72M to $49.93M.
- What is the long-term trend for Denali Therapeutics Inc.'s PP&E (net)?
- Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s PP&E (net) has grown at a 5.1% compound annual growth rate (CAGR), from $40.85M to $52.4M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Denali Therapeutics Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude